ArticlePharmaceutical research2018

Dihydroceramide Desaturase 1 Inhibitors Reduce Amyloid-β Levels in Primary Neurons from an Alzheimer's Disease Transgenic Model.

Lara Ordóñez-Gutiérrez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.